Met Life Investment Management, LLC Axogen, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 23,715 shares of AXGN stock, worth $299,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,715
Previous 23,715 -0.0%
Holding current value
$299,757
Previous $171,000 94.15%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$5.67 - $8.06 $33,674 - $47,868
5,939 Added 33.41%
23,715 $171,000
Q1 2024

May 14, 2024
BUY
$6.63 - $10.69 $117,854 - $190,025
17,776 New
17,776 $143,000
Q2 2023

Apr 29, 2024
BUY
$8.5 - $10.38 $196,044 - $239,404
23,064 New
23,064 $210,000
Q1 2023

May 09, 2024
BUY
$7.53 - $10.95 $173,671 - $252,550
23,064 New
23,064 $218 Million
Q1 2022

May 10, 2024
BUY
$7.26 - $10.7 $167,444 - $246,784
23,064 New
23,064 $183,000
Q1 2022

Mar 22, 2023
BUY
$7.26 - $10.7 $59,706 - $87,996
8,224 Added 55.42%
23,064 $183,000
Q1 2022

May 12, 2022
BUY
$7.26 - $10.7 $59,706 - $87,996
8,224 Added 55.42%
23,064 $183,000
Q4 2021

May 17, 2024
BUY
$8.8 - $16.0 $39,767 - $72,304
4,519 Added 43.78%
14,840 $139,000
Q4 2021

Jun 21, 2023
SELL
$8.8 - $16.0 $72,371 - $131,584
-8,224 Reduced 35.66%
14,840 $139,000
Q4 2021

Mar 22, 2023
BUY
$8.8 - $16.0 $39,767 - $72,304
4,519 Added 43.78%
14,840 $139,000
Q4 2021

Feb 15, 2022
BUY
$8.8 - $16.0 $39,767 - $72,304
4,519 Added 43.78%
14,840 $139,000
Q3 2021

May 17, 2024
SELL
$15.23 - $21.72 $78,510 - $111,966
-5,155 Reduced 33.31%
10,321 $163,000
Q3 2021

Jun 21, 2023
SELL
$15.23 - $21.72 $194,075 - $276,777
-12,743 Reduced 55.25%
10,321 $163,000
Q3 2021

Mar 22, 2023
SELL
$15.23 - $21.72 $78,510 - $111,966
-5,155 Reduced 33.31%
10,321 $163,000
Q3 2021

Nov 15, 2021
SELL
$15.23 - $21.72 $78,510 - $111,966
-5,155 Reduced 33.31%
10,321 $163,000
Q2 2021

Jun 21, 2023
SELL
$17.8 - $23.5 $135,066 - $178,318
-7,588 Reduced 32.9%
15,476 $334,000
Q1 2021

May 17, 2024
SELL
$17.18 - $22.6 $39,514 - $51,980
-2,300 Reduced 12.94%
15,476 $313,000
Q1 2021

Jun 26, 2023
SELL
$17.18 - $22.6 $130,361 - $171,488
-7,588 Reduced 32.9%
15,476 $314 Million
Q4 2020

Jun 22, 2023
SELL
$11.5 - $17.96 $87,262 - $136,280
-7,588 Reduced 32.9%
15,476 $277,000
Q3 2020

Jun 26, 2023
SELL
$10.62 - $13.12 $80,584 - $99,554
-7,588 Reduced 32.9%
15,476 $179,000
Q2 2020

May 24, 2024
SELL
$7.35 - $10.81 $16,905 - $24,863
-2,300 Reduced 12.94%
15,476 $143 Million
Q2 2020

Jun 26, 2023
SELL
$7.35 - $10.81 $55,771 - $82,026
-7,588 Reduced 32.9%
15,476 $142,000
Q1 2020

Jul 12, 2023
SELL
$8.38 - $17.34 $63,587 - $131,575
-7,588 Reduced 32.9%
15,476 $160,000
Q4 2019

Jul 12, 2023
SELL
$11.18 - $18.6 $84,833 - $141,136
-7,588 Reduced 32.9%
15,476 $276,000
Q3 2019

Jul 12, 2023
SELL
$12.09 - $20.46 $91,738 - $155,250
-7,588 Reduced 32.9%
15,476 $193,000
Q2 2019

Jul 12, 2023
SELL
$18.5 - $25.47 $140,378 - $193,266
-7,588 Reduced 32.9%
15,476 $306,000
Q1 2019

Jul 13, 2023
SELL
$14.62 - $22.13 $110,936 - $167,922
-7,588 Reduced 32.9%
15,476 $325,000
Q4 2018

Jul 13, 2023
SELL
$17.09 - $38.25 $129,678 - $290,241
-7,588 Reduced 32.9%
15,476 $316,000
Q4 2018

Mar 22, 2023
SELL
$17.09 - $38.25 $145,880 - $326,502
-8,536 Reduced 35.55%
15,476 $316,000
Q4 2018

Feb 14, 2019
SELL
$17.09 - $38.25 $145,880 - $326,502
-8,536 Reduced 35.55%
15,476 $316,000
Q3 2018

Jul 13, 2023
SELL
$34.05 - $55.9 $258,371 - $424,169
-7,588 Reduced 32.9%
15,476 $570,000
Q3 2018

Mar 22, 2023
BUY
$34.05 - $55.9 $32,279 - $52,993
948 Added 4.11%
24,012 $884,000
Q3 2018

Nov 14, 2018
BUY
$34.05 - $55.9 $290,650 - $477,162
8,536 Added 55.16%
24,012 $885,000
Q2 2018

Aug 15, 2018
BUY
$36.15 - $52.5 $63,551 - $92,295
1,758 Added 12.82%
15,476 $778,000
Q4 2017

Feb 15, 2018
BUY
$18.5 - $28.6 $253,783 - $392,334
13,718
13,718 $388,000

Others Institutions Holding AXGN

# of Institutions
163
Shares Held
36.6M
Call Options Held
230K
Put Options Held
400
View Full List

About Axogen, Inc.

AXGN Quotes by TradingView
  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $534M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email